Obesity , high blood sugar and high blood pressure among other metabolic issues now lead to almost 50 per cent more years of healthy life lost to either disease or premature death than in 2000, a major international study showed on Thursday.
The Global Burden of Diseases, Injuries and Risk Factors Study 2021, published on Thursday in The Lancet, used data from 204 countries and territories to identify the leading causes worldwide of illness and early death. These are measured in disability-adjusted life years, or “DALYs.” They also pointed out that the results were not uniform. Undernutrition remained a major risk factor in sub-Saharan Africa, for example.
“Future trends may be quite different than past trends because of factors such as climate change and increasing obesity and addiction,” said Liane Ong, lead research scientist at the Institute for Health Metrics and Evaluation at the University of Washington, which led the study.
Source: Healthcare Press (healthcarepress.net)
Years Cent Death Obesity Undernutrition Life Health University Of Washington Africa Global Burden Of Diseases
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Africa’s Biggest Drugmaker Can Help Ease Obesity Medicine Supply CrunchAfrica’s biggest drugmaker could potentially help ease a growing supply crunch for the world’s hottest obesity medications.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Novo to Pay Up to $600 Million in Latest Obesity R&D DealNovo Nordisk A/S, maker of hit drugs Ozempic and Wegovy, signed its third research deal with a biotech backed by Flagship Pioneering, agreeing to pay as much as $600 million to develop next-generation obesity treatments.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityThe weight-loss drug Wegovy, made by the manufacturers of Ozempic, will be available to patients in Canada starting Monday, the company says. Novo Nordisk's weekly injection is approved for weight loss among patients diagnosed with obesity.
Source: PGCitizen - 🏆 65. / 51 Read more »
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityThe weight-loss drug Wegovy, made by the manufacturers of Ozempic, will be available to patients in Canada starting Monday, the company says. Novo Nordisk's weekly injection is approved for weight loss among patients diagnosed with obesity.
Source: SooToday - 🏆 8. / 85 Read more »
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityThe weight-loss drug Wegovy, made by the manufacturers of Ozempic, will be available to patients in Canada starting Monday, the company says. Novo Nordisk's weekly injection is approved for weight loss among patients diagnosed with obesity.
Source: BurnabyNOW_News - 🏆 14. / 77 Read more »
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityThe weight-loss drug Wegovy, made by the manufacturers of Ozempic, will be available to patients in Canada starting Monday, the company says. Novo Nordisk's weekly injection is approved for weight loss among patients diagnosed with obesity.
Source: sudburydotcom - 🏆 6. / 89 Read more »